FSSAI Takes Action Against Nestlé India Over Infant Food Claims, Biotin I Economy India
5 Articles
5 Articles
A tin of formula asks for total trust. Nestle's labels may not have earned it
FSSAI has opened three cases against Nestle India over claims on NAN Excella and Lactogen Pro, and a biotin shortfall found in a separate follow-up formula. We explain why a baby cannot read a label, question a claim or choose another meal, making this one category where marketing and harm sit dangerously close.
India's Food Safety Authority (FSSAI) determined that the biotin content in Nestlé's infant follow-up formula products fell short of the standard, and initiated 3 legal proceedings against Nestlé on the 18th. FSSAI stated that Nestlé's follow up formula samples were “defective products that do not meet biotin standards.” Biotin is a nutrient also known as vitamin B7, and FSSAI defines the standard content range applied to baby food products, and…
Is Nestlé A Dangerous Brand? From Lactogen And Cerelac In India To Formula Investigations Abroad, Why Does Its Infant-Nutrition Business Keep Coming Under Scrutiny?
Nestlé India is facing fresh regulatory action over the way it markets some of its infant nutrition products, with the Food Safety and Standards Authority of India filing three adjudication cases concerning NAN Excella Pro Stage 1 and Lactogen Pro 1. The action follows scrutiny of promotional material and product listings on e-commerce platforms, putting …
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
